The comparison of plasma D-dimer levels in benign and malignant tumors of cervix, ovary and uterus
,
Abstract
Background: Thromboembolism is the most important complication of cancers.The aim of this study was to determine D-dimer levels in benign and malignant tumors of the uterus, ovary and cervix.
Subjects and Methods: This was a cross sectional study and it was conducted on 90 female patients referred to Imam Khomeini and Arash Hospitals because of uterine, cervical and ovarian tumors in 2013-2014. After surgical resection or tissue biopsy, 2 cc of each patient’s blood was taken to be sent to laboratory of hospitals. “Nycocard” kit was chosen to measure D-dimer levels in Mg/Lit by neflumetry method. Data were analyzed in SPSS-16 by T-test and One-Way ANOVA test.
Results: The highest mean of D-dimer was 3.9 (± 2.9SD) in malignant cervical tumors. The mean plasma levels of D-dimer in malignant uterine cancers (P = 0.008), ovarian cancers (P = 0.007) and cervical cancers (P = 0.006) was significantly higher than benign tumors. In all three types of uterine, ovarian and cervical cancers, D-dimer was significantly higher in advanced stages than lower stages.
Conclusion: The plasma D-dimer levels in patients with malignant tumors of the uterus, cervix and ovary were higher than benign types. By increasing the stage of gynecologic malignant tumors, the levels of plasma D-dimer were increased.
Hoffman K, Nekhlyudov L, Deligdisch L. Endometrial carcinoma in elderly women. Gynecol Oncol. 1995; 8:198-201.
Jennifer CO, Gregory F, Gini F. Chemotherapy in endometrial cancer. Clin advanc hematol oncol. 2006; 4: 459-68.
. Devita VT, Hellman S, Rosenberg SA. DeVita, Hellman, and Rosenberg's Cancer: Principles & Practice of Oncology. 7th ed. Philadelphia: Lippincott Williams & Wilkins. 2005.
Disaia PJ, Creasman WT. Epithelial ovarian cancer. In: Disaia PJ, Creasman WT, Editors. 6th ed. Philadelphia: St Louis: Mosby: 2002. p. 289-350.
Parkin DM, Bray F, Ferlay J, et al. Global cancer statistics, 2002, CA Cancer J Clin. 2005; Mar-Apr. 55 (2): 74-108.
Visintin, Irene. "Diagnostic markers for early detection of ovarian cancer." Clinical Cancer Research; 2008. 14(4): 1065-1072.
Falanga A, Donati MB. Pathogenesis of thrombosis in patients with malignancy. Int J Hematol. 2001; 73: 137-44.
Donati MB. Cancer and thrombosis. Haemostasis. 1994; 24: 128-31
Mousa SA. Anticoagulants in thrombosis and cancer: The missing link. Semin Thromb Hemost. 2002; 28:45-52.
Rickles FR, Edwards RL, Barb C. Abnormalities of blood coagulation in patients with cancer: fibrinopeptide A generation and tumor growth. Cancer (Phila).1983; 51: 301–7.
Sorensen HT, Mellemkjaer L, Olsen JH, et al. Prognosis of cancers associated with venous thromboembolism. N Engl J Med; 2000. 343: 1846-50.
Sampson MT, Kakkar AK. Coagulation proteases and human cancer. Biochem Soc Trans. 2002; 30: 201-207.
Cushman M, Folsom AR, Wang L. Fibrin fragment D-dimer and the risk of future venous thrombosis. Blood. 2003;101:1243-1248.
Lippi G, Franchini M, Targher G, et al. Help me, Doctor! My D-dimer is raised. Ann Med. 2008; 40: 594- 605.
Kuderer NM, Ortel TL, Francis CW. Impact of venous thromboembolism and anticoagulation on cancer and cancer survival. J Clin Oncol. 2009; 27(29):4902 11.
Nagy Z, Horv´ath O, K´adas J. “D-dimer as a potential prognostic marker,” Pathology and Oncology Research. 2012; 18: 669–674.
Tas F, Kilic L, Serilmez M, et al. Clinical and prognostic significance of coagulation assays in lung cancer. Respir Med. 2013; 107:451–457.
Vossen CY, Hoffmeister M, Chang-Claude JC, et al. Clotting factor gene polymorphisms and colorectal cancer risk. J Clin Oncol. 2011; 29(13): 1722-7.
Caine GJ, Lip GY, Stonelake PS, et al. Platelet activation, coagulation and angiogenesis in breast and prostate carcinoma. Thromb Haemost. 2004; 92: 185–90.
Toth B, Nieuwland R, Liebhardt S, et al. Circulating microparticles in breast cancer patients: A comparative analysis with established biomarkers. Anticancer Res. 2008; 28: 1107– 1112.
Von Tempelhoff GF, Dietrich M, Niemann F. Blood coagulation and thrombosis in patients with ovarian malignancy. Thromb Haemost. 1997; 77:456 461.
Oya M, Akiyama Y, Okuyama T, et al. High preoperative plasma D-dimer level is associated with advanced tumor stage and short survival after curative resection in patients with colorectal cancer. Jpn J Clin Oncol. 2001;31: 388394.
Rose PG, Terrien JM, Baker S. Plasma Ddimer and peritoneal CA-125 levels as predictors of disease status in ovarian carcinoma. J Surg Oncol. 1994; 56(3):168-71.
Yousef GM, Polymeris ME, Yacoub GM, et al. Parallel overexpression of seven kallikrein genes in ovarian cancer. Cancer Res. 2003; 63:2223-2227
Polteraue R.S, Grimm C, Husslein H, et al. The prognostic value of plasma fibrinogen levels in patients with endometrial cancer: a multi-centre trial V Seebacher. British Journal of Cancer. 2010; 102, 952 – 956.
Sahni A, Simpson-Haidaris PJ, Sahni SK, et al. Fibrinogen synthesized by cancer cells augments the proliferative effect of fibroblast growth factor-2 (FGF-2). J Thromb Haemost. 2008; 6: 176–183.
Lawrence SO, Simpson-Haidaris PJ. Regulated de novo biosynthesis of fibrinogen in extrahepatic epithelial cells in response to inflammation. Thromb Haemost. 2004; 92: 234–243.
Palumbo JS, Kombrinck KW, Drew AF, et al. Fibrinogen is an important determinant of the metastatic potential of circulating tumor cells. Blood. 2000; 96: 3302–3309.
Palumbo JS, Talmage KE, Massari JV, et al. Platelets and fibrin-(ogen) increase metastatic potential by impeding natural killer cell mediated elimination of tumor cells. Blood. 2005; 105: 178–185.
Satoh T, Mastumoto K, Uno K. Silent venous thromboembolism before treatment in endometrial cancer and the risk factors. Brit J Cancer. 2008; 99: 1034-1039.
Boing AN, Hau CM, Sturk A, et al. Platelet microparticles contain active caspase. Platelets. 2008 Mar; 19(2): 96-103.
Lopes, A, Daras V, Cross P A, et al. Thrombocytosis as a prognostic factor in women with cervical cancer. Cancer; 1994. 74, 90–92.
Hernandez E, Lavine M, Dunto n CJ, et al. Poor prognosis associated with thrombocytosis in patients with cervical cancer. Cancer. 1992; 69: 2975–7.
| Files | ||
| Issue | Vol 9, No 3 (2015) | |
| Section | Articles | |
| Keywords | ||
| Coagulation D-dimer Gynecologic Tumors Tromboembolism | ||
| Rights and permissions | |
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
